Travere Therapeutics TVTX
NASDAQ TVTX
$65.28 -1.26 (-1.89%)
As of: Sep 4, 2026 · 3:59 PM EDT

Travere Therapeutics (TVTX) Amortizatization of Intangibles (2011 - 2023)

Travere Therapeutics' (TVTX) quarterly Amortizatization of Intangibles came in at $2.3 million in Q4 2023, up 122.39% YoY from $1.0 million in Q4 2022, and up 22.84% on a QoQ basis from $1.9 million in Q3 2023.

Analysis

Travere Therapeutics (TVTX) Amortizatization of Intangibles (2011 - 2023) Analysis & Trends

Travere Therapeutics (TVTX) has 11 years of Amortizatization of Intangibles data on file, last reported at $2.3 million in Q4 2023.

  • Quarterly Amortizatization of Intangibles rose 122.39% year-over-year to $2.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $5.7 million (up 717.43% YoY) and the FY2025 annual result came in at $4.4 million, down 2.18% from the prior year.
  • Amortizatization of Intangibles rose to $2.3 million in Q4 2023, from $1.9 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.3 million in Q4 2023 to a low of -$697000.0 in Q4 2021.
  • A 5-year average of $161333.3 and a median of -$155500.0 in 2020 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2019 — Amortizatization of Intangibles soared 295.1% — and 2020, when it sank 2022.22%.
  • Tracing TVTX's Amortizatization of Intangibles over 5 years: stood at $9000.0 in 2019, then slumped by 2022.22% to -$173000.0 in 2020, then plunged by 302.89% to -$697000.0 in 2021, then soared by 246.77% to $1.0 million in 2022, then jumped by 122.39% to $2.3 million in 2023.
  • The last three Amortizatization of Intangibles figures came in at $2.3 million (Q4 2023), $1.9 million (Q3 2023), and $1.0 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Travere Therapeutics 6.11 Bn 6.11 Bn 162.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.28 Mn
Sep 30, 2023 1.85 Mn
Dec 31, 2022 1.02 Mn
Sep 30, 2022 572,000.00
Jun 30, 2022 -222,000.00
Mar 31, 2022 -673,000.00
Dec 31, 2021 -697,000.00
Sep 30, 2021 -651,000.00
Jun 30, 2021 -483,000.00
Mar 31, 2021 -177,000.00
Dec 31, 2020 -173,000.00
Sep 30, 2020 -193,000.00
Jun 30, 2020 -199,000.00
Mar 31, 2020 -138,000.00
Dec 31, 2019 9,000.00
Sep 30, 2019 199,000.00
Jun 30, 2019 237,000.00
Mar 31, 2019 343,000.00
Dec 31, 2018 1.21 Mn
Sep 30, 2018 -102,000.00